Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC)

References

• WHO Director-General. WHO Director-General’s opening remarks at the media briefing on COVID- 19: 11 March 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed May 04, 2020.
   Google Scholar
• Arshad Ali S, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. The outbreak of Coronavirus disease 2019 (COVID-19)-an emerging global health threat. J Infect Public Health. 2020;13(4):644‐646. doi:10.1016/j.jiph.2020.02.033
   Web of Science ®Google Scholar
• Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4(5):e10‐e11. doi:10.1016/S2352-4642(20)30108-5
   Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 patients [published online ahead of print, 2020 Apr 21]. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.04.028.
   Web of Science ®Google Scholar
• Khavandi S, Tabibzadeh E, Naderan M, Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic [published online ahead of print, 2020 Apr 27]. Cont Lens Anterior Eye. 2020;43(3):SS1367. doi:10.1016/j.clae.2020.04.010
   Web of Science ®Google Scholar
• Hamroush A, Qureshi M, Shah S. Increased risk of ocular injury seen during lockdown due to COVID-19 [published online ahead of print, 2020 Apr 27]. Cont Lens Anterior Eye. 2020;43(3). doi:10.1016/j.clae.2020.04.007
   Web of Science ®Google Scholar
• Lim LW, Yip LW, Tay HW, et al. Sustainable practice of ophthalmology during COVID-19: challenges and solutions [published online ahead of print, 2020 Apr 21]. Graefes Arch Clin Exp Ophthalmol. 2020;258:1‐10. doi:10.1007/s00417-020-04682-z
   Web of Science ®Google Scholar
• WHO. Strengthening the health system response to COVID-19 recommendations for the WHO European Region Policy brief (1 April 2020). Available from: http://www.euro.who.int/en/health-topics/Health-systems/pages/strengthening-the-health-system-response-to-covid-19/strengthening-the-health-system-response-to-covid-19-policy-brief. Accessed May 05, 2020.
   Google Scholar
• Qiao C, Zhang H, He M, et al. Symptomatic COVID-19 in Eye Professionals in Wuhan, China [published online ahead of print, 2020 Apr 18]. Ophthalmology. 2020;127(9):SS0161–SS0166. doi:10.1016/j.ophtha.2020.04.026
   Web of Science ®Google Scholar
• Jørstad ØK, Moe MC, Eriksen K, Petrovski G, Bragadóttir R. Coronavirus disease 2019 (COVID-19) outbreak at the department of ophthalmology, Oslo University Hospital, Norway. Acta Ophthalmol. 2020;98(3):e388‐e389. doi:10.1111/aos.14426
   Web of Science ®Google Scholar
• RANZCO: 28/04/2020 RANZCO NZ Branch guidance: change to COVID-19 level 3. Available from: https://ranzco.edu/wp-content/uploads/2020/04/RANZCO-Level-3-NZ-Guidelines-22-April-2020.GS_.pdf. Accessed May 04, 2020.
   Google Scholar
• AAO: 18/03/2020 Recommendations for urgent and nonurgent patient care. Available from: https://www.aao.org/headline/new-recommendations-urgent-nonurgent-patient-care. Accessed May 04, 2020.
   Google Scholar
• ASRS: 14/04/2020 COVID-19: updates and Resources. Available from: https://www.asrs.org/practice/asrs-member-alert-regarding-covid-19-pandemic. Accessed May 04, 2020.
   Google Scholar
• RCOphth: management of ophthalmology services during the Covid pandemic. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2020/03/RCOphth-Management-of-Ophthalmology-Services-during-the-Covid-pandemic-280320.pdf. Accessed May 04, 2020.
   Google Scholar
• Williams AM, Kalra G, Commiskey PW, et al. Ophthalmology practice during the Coronavirus disease 2019 pandemic: the University of Pittsburgh experience in promoting clinic safety and embracing video visits [published online ahead of print, 2020 May 6]. Ophthalmol Ther. 2020. doi:10.1007/s40123-020-00255-9
   Web of Science ®Google Scholar
• Saleem SM, Pasquale LR, Sidoti PA, Tsai JC. Virtual ophthalmology: telemedicine in a Covid-19 Era [published online ahead of print, 2020 Apr 30]. Am J Ophthalmol. 2020;216:237–242. doi:10.1016/j.ajo.2020.04.029
   PubMed Web of Science ®Google Scholar
• RCOphth: 30/03/2020 medical retinal management plans during COVID-19. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2020/03/Medical-Retinal-Management-Plan-during-COVID-19-UPDATED-300320-1-3.pdf. Accessed May 04, 2020.
   Google Scholar
• Gupta S, Jangra RS, Gujrathi AV, et al. A novel clinical set up for examining healthy dermatology outpatients in time of Covid-19 [published online ahead of print, 2020 Apr 18]. Clin Exp Dermatol. 2020. doi:10.1111/ced.14246
   Web of Science ®Google Scholar
• Amoaku W, Balaskas K, Cudrnak T, et al. Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group. Clin Ophthalmol. 2018;12:1731‐1740. doi:10.2147/OPTH.S174560
   Web of Science ®Google Scholar
• Deutsche Ophthalmologische Gesellschaft. Coronavirus Covid 19. Available from: https://www.dog.org/?cat=288. Accessed May 04, 2020.
   Google Scholar
• Public Health England. Recommended PPE for primary, outpatient, community and social care by setting, NHS and independent sector 19. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/878750/T2_poster_Recommended_PPE_for_primary__outpatient__community_and_social_care_by_setting.pdf. Accessed May 12, 2020.
   Google Scholar
• RCOphth PPE and staff protection requirements for ophthalmology. Available from: https://www.rcophth.ac.uk/wp-content/uploads/2020/04/UPDATED-RCOphth-PPE-for-ophthalmology-090420.pdf. Accessed May 12, 2020.
   Google Scholar
• European Centre for Disease Prevention and Control. Considerations relating to social distancing measures in response to COVID-19 – second update. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-social-distancing-measuresg-guide-second-update.pdf. Accessed May 14, 2020.
   Google Scholar
• European Centre for Disease Prevention and Control. Infection prevention and control for COVID-19 in healthcare settings - first update. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-infection-prevention-and-control-healthcare-settings-march-2020.pdf. Accessed May 14, 2020.
   Google Scholar
• Liu YA, Hsu YC, Lin MH, et al. Hospital visiting policies in the time of COVID-19: a nationwide website survey in Taiwan [published online ahead of print, 2020 Apr 21]. J Chin Med Assoc. 2020;83:566–570. doi:10.1097/JCMA.0000000000000326
   Web of Science ®Google Scholar
• Wykoff CC, Ou WC, Croft DE, et al. Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. Br J Ophthalmol. 2018;102(4):460‐464. doi:10.1136/bjophthalmol-2017-310822
   Web of Science ®Google Scholar
• Yang Y, Downey L, Mehta H, et al. Resource use and real-world outcomes for ranibizumab treat and extend for neovascular age-related macular degeneration in the UK: interim results from TERRA. Ophthalmol Ther. 2017;6(1):175‐186. doi:10.1007/s40123-017-0091-9
   Google Scholar
• Hufendiek K, Pielen A, Framme C. Injektionsstrategien bei der anwendung intravitrealer VEGF-inhibitoren: pro re nata versus treat and extend“ [strategies of intravitreal injections with anti-VEGF: “pro re nata versus treat and extend”]. Klin Monbl Augenheilkd. 2018;235(8):930‐939. doi:10.1055/s-0042-122340
   Web of Science ®Google Scholar
• Rayat JS, Grewal PS, Whelan J, Tennant MT, Choudhry N. Canadian preference and trends survey results for anti-VEGF treatment of macular edema. Can J Ophthalmol. 2016;51(3):233‐237. doi:10.1016/j.jcjo.2015.10.014
   Web of Science ®Google Scholar
• Ghosh W, Wickstead R, Claxton L, et al. The cost-effectiveness of ranibizumab treat and extend regimen versus aflibercept in the UK. Adv Ther. 2016;33(9):1660‐1676. doi:10.1007/s12325-016-0367-9
   Web of Science ®Google Scholar
• NICE Guideline. Age related macular degeneration. Available from: https://www.nice.org.uk/guidance/ng82/chapter/Recommendations#diagnosis-and-referral. Accessed May 04, 2020.
   Google Scholar
• Kang S, Thomas PBM, Sim DA, Parker RT, Daniel C, Uddin JM. Oculoplastic video-based telemedicine consultations: Covid-19 and beyond [published online ahead of print, 2020 May 12]. Eye (Lond). 2020;34:1193–1195. doi:10.1038/s41433-020-0953-6
   PubMed Web of Science ®Google Scholar
• Jayaram H, Strouthidis NG, Gazzard G. The COVID-19 pandemic will redefine the future delivery of glaucoma care. Eye (Lond). 2020;34:1203–1205. doi:10.1038/s41433-020-0958-1
   Web of Science ®Google Scholar
• Greaney ML, Sprunck-Harrild K, Ruddy KJ, et al. Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health. 2015;15:37. doi:10.1186/s12889-015-1346-9
   Web of Science ®Google Scholar
• Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C, Rees G. Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychol Health Med. 2018;23(2):127‐140. doi:10.1080/13548506.2016.1274040
   Web of Science ®Google Scholar